<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        27-883-19
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        TILDIEM 60MG TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DILTIAZEM HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        60
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        16.6
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="sanofi-aventis" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            sanofi-aventis
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 2218]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Sanofi Arabia Trading Co. Ltd
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Sanofi Aventis France
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C08DB01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pharmacotherapeutic group<br />SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS/<br />BENZOTHIAZEPINE DERIVATIVES<br />This medicine belongs to the class of calcium channel blockers.<br />Therapeutic indications<br />This medicine is used to prevent angina attacks (symptoms related to failure of the<br />blood vessels that supply blood to the heart), particularly in patients with effort<br />angina or unstable angina including variant angina.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Contraindications<br />If you have been told by your doctor that you are intolerant to some sugars, contact<br />him/her before taking this medicine.<br />Do not take Tildiem 60 mg tablets in the following situations:<br />&bull; allergy to diltiazem or to any of the other ingredients<br />&bull; very slow heart rate (less than or equal to 40 beats per minute)<br />&bull; sinus node dysfunction (heart rate disorder)<br />&bull; second- or third-degree atrioventricular block not corrected by a pacemaker (heart<br />conductiondisorders)<br />&bull; left ventricular failure with congestion in the lungs (impaired heart function)<br />&bull; incombinationwithdantrolene(byinfusion),pimozide,cisapride,dihydroergotamine,<br />ergotamine, nifedipine, sertindole.<br />Unless otherwise indicated by your doctor, this medicine should generally not be used during pregnancy or in combination with esmolol (in certain cases), beta- blockers used for the treatment of heart failure (bisoprolol, carvedilol, metoprolol, nebivolol), other beta-blockers, ivabradine or triazolam.<br />Precautions for use; special warnings<br />Take special care with Tildiem 60 mg tablets<br />Special warnings<br />This medicine contains castor oil which can cause digestive disorders (mild laxative<br />effect, diarrhea).<br />This medicine should not be used in patients with galactose intolerance, Lapp lactase<br />deficiency or glucose/galactose malabsorption syndrome (rare hereditary diseases).<br />ALWAYS KEEP OUT OF THE REACH OF CHILDREN.<br />Precautions for use<br />This medicine should be used WITH CAUTION:<br />&bull; in elderly subjects,<br />&bull; in patients with kidney or liver failure,<br />&bull; in patients with low heart rate or certain heart conduction disorders.<br />If you are to undergo general anesthesia, tell your doctor that you are taking diltiazem. This medicine can be associated with mood disorders (for example, depression). This medicine acts on intestinal motility. It must be used with caution in patients at risk of developing an intestinal obstruction.<br />Follow your doctor&rsquo;s advice.<br />Other medicines and Tildiem 60 mg tablets<br />TO AVOID POSSIBLE INTERACTIONS BETWEEN SEVERAL MEDICINES, particularly</p><p>if you are taking dantrolene (infusion), pimozide, cisapride, dihydroergotamine, ergotamine, nifedipine, sertindole, esmolol (in certain cases), beta-blockers used in the treatment of heart failure (bisoprolol, carvedilol, metoprolol, nebivolol), other beta-blockers, ivabridine or triazolam.<br />ALWAYS INFORM YOUR DOCTOR OR PHARMACIST OF ANY OTHER TREATMENT YOU MAY BE TAKING.<br />Pregnancy and breast-feeding Pregnancy<br />Use of this medicine is not recommended during pregnancy or in women of child- bearing age who are not using contraception. If you discover that you are pregnant, tell your doctor immediately and follow his/her instructions with regard to your treatment. Tell your doctor if you are planning to have a baby.<br />Breast-feeding<br />This medicince should be avoided if you are breast-feeding. If the use of Tildiem 60 mg tablets is necessary, the infant should be fed using an alternative method (bottles, etc.). Ask your doctor or pharmacist for advice before taking any medicine.<br />Driving and using machines<br />The ability to drive or use machines may be impaired.<br />List of excipients with specific effects: hydrogenated castor oil, lactose.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>How many Tildiem 60 mg tablets you should take<br />Adults: The usual dosage is 1 tablet 3 times daily.<br />Dosage depends on the patient&rsquo;s condition and medical prescription.<br />Children: As the safety and efficacy of this medicine have not been demonstrated in this population, diltiazem should not be used in children.<br />STRICTLY FOLLOW YOUR DOCTOR&rsquo;S PRESCRIPTION.<br />How Tildiem 60 mg tablets should be taken<br />Oral use.<br />Tablets should not be chewed, but swallowed whole with a glass of water.<br />How often Tildiem 60 mg tablets should be taken<br />Take this medicine at each of the 3 meals of the day, preferably at the beginning of the meal.<br />How long Tildiem 60 mg tablets should be taken<br />STRICTLY FOLLOW YOUR DOCTOR&rsquo;S PRESCRIPTION.<br />If you take more Tildiem 60 mg tablets than you should If you take too high a dose, call your doctor immediately. If you forget to take Tildiem 60 mg tablets<br />Contact your doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Tildiem 60 mg tablets can cause side effects, although not everybody gets them.<br />In general, the frequency of side effects is classed as follows:<br />&bull; very common (more than 1 in 10 patients),<br />&bull; common (more than 1 in 100 patients and less than 1 in 10 patients),<br />&bull; uncommon (more than 1 in 1,000 patients and less than 1 in 100 patients),<br />&bull; rare (more than 1 in 10,000 patients and less than 1 in 1,000 patients),<br />&bull; very rare (less than 1 in 10,000 patients).<br />Heart disorders:<br />&bull; Common: certain heart conduction disorders, palpitations,<br />&bull; Uncommon: poorly tolerated slow heart rate,<br />&bull; Not known: congestive heart failure, other heart conduction disorders.<br />Vascular disorders:<br />These disorders are related to the way the medicine works and occur more readily in elderly subjects.Common: flushing,<br />&bull; Uncommon: postural hypotension,<br />&bull; Not known: inflammation of the small blood vessels (vasculitis).<br />Digestive disorders:<br />&bull; Common: constipation, stomach ache, nausea, dyspepsia,<br />&bull; Uncommon: vomiting, diarrhea,<br />&bull; Rare: dry mouth,<br />&bull; Not known: excessive enlargement of the gums.<br />Skin disorders:<br />&bull; Common: erythema,<br />&bull; Rare: hives,<br />&bull; Not known:<br />- sudden swelling of the face and neck (angioedema) of allergic origin,<br />- various types of skin rash, such as erythema multiforme (in particular<br />Stevens-Johnson syndrome and toxic epidermal necrolysis), acute generalized<br />exanthematous pustulosis (mucous membrane damage or blister-like skin<br />reactions): stop treatment immediately and consult your doctor,<br />- skin reactions triggered by exposure to the sun or UV rays (photosensitization<br />reactions such as lichenoid keratosis on areas of exposed skin),</p><p>- sweating,<br />- erythema, sometimes with fever and/or desquamation,<br />- rash,<br />Liver disorders:<br />&bull; Uncommon: increase in hepatic enzymes (generally temporary),<br />&bull; Not known: clinical hepatitis reversible on treatment discontinuation.<br />Nervous system disorders:<br />&bull; Common: headache, dizziness,<br />&bull; Not known: extrapyramidal symptoms (disorder with rigidity, trembling, and<br />abnormal movements), generally reversible on treatment discontinuation.<br />Psychiatric disorders:<br />&bull; Uncommon: nervousness, insomnia,<br />&bull; Not known: mood changes (especially depression).<br />Reproductive system disorders:<br />&bull; Not known: breast swelling in men, reversible on treatment discontinuation.<br />Blood and lymphatic system disorders:<br />&bull; Not known: reduction in the number of platelets in the blood.<br />General disorders:<br />&bull; Very common: swelling of the lower limbs,<br />&bull; Common: faintness, fatigue.<br />If you notice any side effects not listed in this leaflet, or if any of the side effects becomes serious, please tell your doctor or pharmacist.<br />To report any side effect(s):<br />Saudi Arabia<br />National Pharmacovigilance &amp; Drug Safety Centre (NPC):<br />Fax: +966-11-205-7662<br />Toll free phone: 8002490000<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npc<br />Sanofi - Pharmacovigilance: SA_Pharmacovigilance@sanofi.com</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.<br />Do not use this medicine after the expiry date which is stated on the box. Store below 25&deg;C.<br />Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is:<br />Diltiazem hydrochloride..............................................60mg<br />For one tablet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Lactose, polyoxyethylene glycol 6000, hydrogenated castor oil, magnesium stearate.
What Tildiem 60 mg tablets look like and contents of the pack
This medicine is supplied as tablets. Box of 30.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorization Holder and Operating Company<br />sanofi-aventis France<br />1-13, boulevard Romain Rolland - 75014 Paris, France</p><p>&nbsp;</p><p>Manufacturer<br />SANOFI WINTHROP INDUSTRIE<br />30-36, avenue Gustave Eiffel - 37100 Tours, France</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                October 2011
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>الفئة الدوائیّة العلاجیّة<br />الحاصرات الانتقائیة لقناة الكلسیوم مع تأثیرات قلبیّة مباشرة / مشتق اّت البنزوثیازیبین.<br />ینتمي ھذا الدواء إلى فئة حاصرات قناة الكلسیوم.<br />دواعي الاستعمال العلاجیّة<br />یُستعمل ھذا الدواء لتفادي نوبات الذبحة الصدریّة (عوارض تتعل قّ بقصور الأوعیة الدمویّة التي<br />تزوّد القلب بالدم) بخاصة لدى المرضى المصابین بالذبحة الجھدیّة أو بالذبحة غیر المستقرّة بما في<br />ذلك الذبحة الصدریّة المتغیّرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>موانع الاستعمال<br />إذا قال لك طبیبك إنكّ تعاني من عدم تحمّل بعض أنواع السكّر، اتصل بھ قبل أخذ ھذا الدواء.<br />لا تأخذ مطلقاً أقراص تیلدییم ٦٠ ملغ في الحالات التالیة:<br /> حساسیّة ضدّ الدیلتیازیم أو ضدّ أيّ من المركّبات الأخرى،</p><p>تباطؤ كبیر في سرعة القلب ( ٤٠ ضربة في الدقیقة أو أقلّ)،<br /> عسر وظیفة عقدة الجیب (اضطرابات في سرعة القلب)،<br /> حصر أذیني بطیني من الدرجة الثانیة أو الثالثة غیر مصحّح بناظمة (اضطرابات في<br />توصیل القلب)،<br /> قصور البُطین الأیسر مع احتقان في الرئتین (خلل وظیفة القلب)،<br /> بالتزامن مع الدانترولین (الذي یُعطى بالتسریب) أو البیموزاید أو السیزابراید أو<br />الدیھایدروإرغوتامین أو الإرغوتامین أو النیفیبیدین أو السرتندول.<br />إلا في حال أشار الطبیب إلى غیر ذلك، یُمنع استعمال ھذا الدواء بصورة عامة خلال فترة الحمل أو<br />بالتزامن مع الإسمولول (في بعض الحالات) أو مع حاصرات البیتا المستعملة لعلاج قصور القلب<br />(بیسوبرولول، كارفیدیلول، میتوبرولول، نیبیفولول) أو مع حاصرات بیتا أخرى أو الإیفابریدین أو<br />التریازولام.<br />محاذیر الاستعمال؛ تحذیرات خاصة<br />إعتمد عنایة خاصة مع أقراص تیلدییم ٦٠ ملغ<br />تحذیرات خاصة<br />یحتوي ھذا الدواء على زیت الخرّوع مما یمكن أن یسبّب اضطرابات ھضمیّة (تأثیر مسھّل معتدل،<br />إسھال).<br />لا یوصى باستعمال ھذا الدواء لدى المرضى المصابین بعدم تحمّل الغالاكتوز أو بنقص لاكتاز لاب<br />أو بتناذر سوء امتصاص الغلوكوز/غالاكتوز (أمراض وراثیّة خطیرة).<br />إحفظ الدواء بعیدًا عن متناول الأطفال دائمًا.<br />محاذیر الاستعمال<br />یجب استعمال ھذا الدواء بحذر:<br /> لدى المرضى المسن یّن،<br /> لدى المرضى الذین یعانون من قصور في الكلى أو الكبد،<br /> لدى المرضى الذین تكون سرعة القلب لدیھم بطیئة أو یعانون من بعض اضطرابات<br />التوصیل القلبیّة.<br />إذا كنت ستخضع لتخدیر عموميّ، أعلم طبیبك أنكّ تأخذ دیلتیازیم.<br />یمكن ربط ھذا الدواء بتعرّض المریض لاضطرابات في المزاج (اكتئاب مثلا )ً.<br />یعمل ھذا الدواء على الحركة المعویّة. لذا یجب استعمالھ بحذر لدى المرضى الذین یواجھون خطر<br />التعرّض لانسداد معويّ.<br />تقیّد بتعلیمات الطبیب.<br />الأدویة الأخرى وأقراص تیلدییم ٦٠ ملغ<br />لتفادي التفاعلات المحتملة بین عدّة أدویة، لا سیّما إذا كنت تأخذ الدانترولین (عن طریق التسریب)<br />أو البیموزاید أو السیزابرید أو الدیھایدروإرغوتامین أو الإرغوتامین أو النیفیبیدین أو السرتندول أو<br />الإسمولول (في بعض الحالات) أو حاصرات البیتا المستعملة لعلاج قصور القلب (بیسوبرولول،</p><p>كارفیدیلول، متوبرولول، نیبیفولول) أو مع حاصرات بیتا أخرى أو الإیفابریدین أو التریازولام، أعلم<br />دائمًا الطبیب أو الصیدلي بأيّ علاج آخر قد تكون تخضع لھ.<br />الحمل والإرضاع<br />الحمل<br />لا یُنصح باستعمال ھذا الدواء خلال فترة الحمل أو لدى النساء في سنّ الإنجاب اللواتي لا یستعملن<br />وسیلة منع حمل. إذا اكتشفت أنكّ حامل، أعلمي طبیبك على الفور وتقیّدي بتعلیماتھ في ما یتعل قّ<br />بعلاجك.<br />أعلمي طبیبك إذا كنت تنوین الحمل.<br />الإرضاع<br />یجب تفادي أخذ ھذا الدواء إذا كنت ترُضِعین. إذا كان من الضروري استعمال أقراص -تیلدییم ٦٠<br />ملغ المغل فّة المطوّ لة الإطلاق، یجب إطعام الطفل عبر استعمال طریقة بدیلة (رضّاعات، إلخ.).<br />استشیري الطبیب أو الصیدلي قبل تناول أيّ دواء.<br />القیادة واستعمال الآلات<br />قد تضعف القدرة على القیادة أو استعمال الآلات.<br />لائحة الأسوغة التي لھا تأثیرات خاصة: زیت الخرّوع المھدرج، اللاكتوز.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>البالغون: تتراوح الجرعة العادیّة بین قرص واحد و ٣ أقراص یومیًا.<br />یتوقفّ مقدار الجرعة على حالة المریض وعلى الوصفة الطبیّة.<br />الأطفال: بما أن ھّ لم یتمّ التثبّت من سلامة ھذا الدواء وفعالیّتھ لدى ھذه الفئة، لا ینبغي استعمال<br />الدیلتیازیم لدى الأطفال.<br />تقیّد بدق ةّ بوصفة الطبیب.<br />كیف یجب أخذ أقراص تیلدییم ٦٠ ملغ<br />عن طریق الفم.<br />لا ینبغي مضغ الأقراص بل یجب بلعھا كاملة مع بعض الماء.<br />ما ھو عدد مرّات تناول أقراص تیلدییم ٦٠ ملغ<br />خذ ھذا الدواء عند كلّ من الوجبات الثلاثة في الیوم. یُفضّل أخذه عند بدایة الوجبة.<br />ما ھي مدّة العلاج بأقراص تیلدییم ٦٠ ملغ<br />تقیّد بدق ةّ بوصفة الطبیب.<br />إذا أخذت جرعة مفرطة من أقراص تیلدییم ٦٠ ملغ<br />إذا أخذت جرعة مفرطة، اتصل بطبیبك على الفور.<br />إذا نسیت أخذ أقراص تیلدییم ٦٠ ملغ<br />اتصل بطبیبك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل الأدویة كل ھّا، قد تسبّب أقراص تیلدییم ٦٠ ملغ تأثیرات جانبیّة لا تصیب المرضى كل ھّم</p><p>بصورة عامة یُحدّد عدد مرّات حصول التأثیرات الجانبیّة على النحو الآتي:<br /> الشائعة جدًا (تصیب أكثر من مریض من أصل ١٠ )،<br /> الشائعة (تصیب أكثر من مریض من أصل ١٠٠ وأقلّ من مریض من أصل ١٠ )،<br /> غیر الشائعة (تصیب أكثر من مریض من أصل ١٠٠٠ وأقلّ من مریض من أصل ١٠٠ )،<br /> النادرة (تصیب أكثر من مریض من أصل ١٠٠٠٠ وأقلّ من مریض من أصل ١٠٠٠ )،<br /> النادرة جدًا (تصیب أقلّ من مریض من أصل ١٠٠٠٠ ).<br />اضطرابات القلب:<br /> الشائعة: بعض اضطرابات التوصیل في القلب، خفقان.<br /> غیر الشائعة: تباطؤ في سرعة القلب یصعب تحمّلھ.<br /> غیر المعروف معدّل حصولھا: قصور القلب الاحتقاني، اضطرابات أخرى في التوصیل<br />في القلب.<br />الاضطرابات الوعائیّة:<br />تتعل قّ ھذه الاضطرابات بالطریقة التي یعمل فیھا الدواء وتحصل أكثر لدى المرضى المسن یّن.<br /> الشائعة: تورّد،<br /> غیر الشائعة: نقص ضغط الدم الوضعي،<br /> غیر المعروف معدّل حصولھا: إلتھاب الأوعیّة الدمویّة الصغیرة (التھاب وعائي).<br />الاضطرابات المعدیّة<br /> الشائعة: إمساك، ألم في المعدة، غثیان، عسر ھضم،<br /> غیر الشائعة: تقیّؤ، إسھال،<br /> النادرة: جفاف في الفم،<br /> غیر المعروف معدّل حصولھا: تورّم اللث ةّ.<br />الاضطرابات الجلدیّة:<br /> غیر الشائعة: حُمامى،<br /> النادرة: شّرى،<br /> غیر المعروف معدّل حصولھا:<br />- تورّم مفاجئ في الوجھ والعنق (خزب وعائي) إرجيّ المنشأ،<br />- أنواع مختلفة من الطفح الجلدي، مثل الحُمامى المتشكّلة (بخاصة تناذر ستیفنز-<br />جونسون والنكروز الجلدي السام)، بُثار طفحي عام وحاد (تضرّر الغشاء المخاطي<br />أو ارتكاسات جلدیّة شبیھة بالتنف طّ): أوقف العلاج على الفور واستشر الطبیب.<br />- ارتكاسات جلدیة من التعرّض للشمس أو للأشعّة ما فوق البنفسجیّة (تحسّس ضوئي<br />مثل الق رُان الحزازاني على المناطق المعرّضة للشمس)،<br />- تعرّق،<br />- حُمامى، أحیان اً مع حمى و/أو تقشّر،<br />- طفح.</p><p>الاضطرابات الكبدیّة:<br /> غیر الشائعة: ارتفاع في الإنزیمات الكبدیّة (عادة ما یكون مؤق تّ اً)،<br /> غیر المعروف معدّل حصولھا: التھاب كبد سریري یزول عند إیقاف العلاج.<br />اضطرابات الجھاز العصبي:<br /> غیر الشائعة: صداع، دوار،<br /> غیر المعروف معدّل حصولھا: عوارض خارج الھرمیّة (اضطراب مع تصل بّ ورجفة<br />وحركات غیر طبیعیّة)، تزول عادة عند إیقاف العلاج.<br />إضطرابات نفسیّة:<br /> غیر الشائعة: عصبیّة، أرق،<br /> غیر المعروف معدّل حصولھا: تغییرات في المزاج (بخاصة اكتئاب).<br />اضطرابات الجھاز التناسلي:<br /> غیر المعروف معدّل حصولھا: تورّم الثدي لدى الرجال یزول عند إیقاف العلاج.<br />اضطرابات في الدم والجھاز اللمفاوي:<br />غیر المعروف معدّل حصولھا: انخفاض في عدد الصفیحات في الدم.<br />اضطرابات عامة:<br /> الشائعة جدًا: تورّم الأطراف السفلى،<br /> الشائعة: إغماء، تعب.<br />للإبلاغ عن الأعراض الجانبی ة<br />المملكة العربیة السعودیة<br />المركز الوطني للتیقظ والسلامة الدوائیة:<br />فاكس: ٠٠٩٦٦١١٢٠٥٧٦٦٢<br />الھاتف المجاني: ٨٠٠٢٤٩٠٠٠٠<br />البرید الإلكتروني: npc.drug@sfda.gov.sa<br />الموقع الإلكتروني: www.sfda.gov.sa/npc<br />سانوفي-التیقظ الدوائي:<br />KSA_Pharmacovigilance@sanofi.com</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>إحفظ الدواء بعیدًا عن نظر الأطفال ومتناولھم.<br />لا تستعمل ھذا الدواء بعد انقضاء تاریخ الصلاحیّة المدوّن على العلبة.<br />إحفظ الدواء في حرارة ما دون ٢٥ درجة مئویّة.<br />لا ینبغي التخلصّ من الأدویة عبر المیاه المبتذلة أو مع النفایات المنزلیّة. اسأل الصیدلي عن كیفیّة<br />التخلصّ من الأدویة غیر المستعملة، فمن شأن ھذه الإجراءات حمایة البیئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفاعلة ھي:<br />ھیدروكلورید الدیلتیازیم.................................................................................. ٦٠ ملغ<br />في القرص الواحد.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">المركّبات الأخرى ھي:<br />لاكتوز، غلیكول البولي أوكسي إیثیلین ٦٠٠٠ ، زیت الخرّوع المھدرج، ستیارات المغنیزیوم</p><p style="text-align:right">یأتي ھذا الدواء على شكل أقراص. علبة من ٣٠ قرصًا.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الشركة حاملة رخصة التسویق والشركة المشغّلة<br />sanofi-aventis France<br />1-13, boulevard Romain Rolland - 75014 Paris &ndash; France</p><p>&nbsp;</p><p>الشركة المصن عّة<br />Sanofi Winthrop Industrie<br />30-36, avenue Gustave Eiffel - 37100 Tours &ndash; France</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            الأوّل 2011
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                TILDIEM 60 mg, Tablet
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Diltiazem hydrochloride 60 mg
For the full list of excipient see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tablet
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Prevention of attacks of angina pectoris, particularly exertional angina, rest angina including variant<br />angina of Prinzmetal.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adults:<br />The usual dosage is 1 x 60 mg tablet three times daily at the start of meals.<br />In severe cases, dosage can be increased to 4 tablets (i.e. 240 mg) or 6 tablets (i.e. 360 mg) daily.<br />Children:<br />As safety and efficacy have not been established, use of diltiazem is not recommended in children.<br />Elderly and patients with impaired hepatic or renal function:<br />The recommended starting dose is one tablet (60mg) twice daily. The heart rate should be measured regularly in these groups of patients and the dose should not be increased if the heart rate falls below 50 beats per minute.<br />Method of administration:<br />Oral use.<br />Tablets should not be chewed but swallowed with a little water.<br />Diltiazem should be used with caution in patients with kidney or liver failure (see section 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                This medicine must never be used in the following situations: hypersensitivity to diltiazem or to any of the excipients sinus node dysfunction second- and third-degree atrioventricular block in patients without a pacemaker left ventricular failurewith pulmonary congestion severe bradycardia (heart rate 40 bpm) in combination with:
o dantrolene administered by infusion o pimozide
o cisapride
o dihydroergotamine o ergotamine
o nifedipine o sertindole.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Diltiazem hydrochloride is generally not recommended in the following situations: In combination with:<br />o esmolol (in patients with impaired left ventricular function)<br />o beta-blockers used in heart failure (bisoprolol, carvedilol, metoprolol, nebivolol)<br />o other beta-blockers o triazolam<br />o ivabradine In pregnant women or women who may be pregnant (see section 4.6) Monitoring should be carried out in patients with impaired left ventricular function, bradycardia<br />(due to risk of exacerbation), or first-degree atrioventricular block on the ECG (due to risk of exacerbation and, in exceptional cases, complete block). However, there are no special precautions for patients with bundle branch block. In elderly subjects and patientswith kidney or liver failure, diltiazem plasma concentrations may<br />be increased. Particular attention should be paid to contraindications and precautions for use. Close monitoring, particularly of heart rate and ECG should be performed at the beginning of treatment.</p><p>Diltiazem is likely to induce a decrease in blood pressure and significant bradycardia, particularly<br />in elderly subjects. Patients due to undergo general anesthesia should inform the anesthesiologist that they are taking<br />diltiazem. During general anesthesia, diltiazem generally triggers a moderate decrease in blood pressure and<br />systemic vascular resistance, as well as a slight slowing of heart rate. The vasodilation induced by anesthetics may be potentiated by diltiazem. Their dose must be adapted to the hemodynamic response. Diltiazem can be used safely in patients with chronic respiratory disorders. Calcium channel blockers such as diltiazem can be associated with mood disorders and, in<br />particular, depression. Like other calcium channel blockers, diltiazem has an inhibitory effect on intestinal motility.<br />Consequently, it must be used with caution in patients at risk of developing an intestinal obstruction. This medicine contains castor oil, which can cause digestive disorders (mild laxative effect,<br />diarrhea). This medicine contains lactose. Its use is not recommended in patients with galactose intolerance,<br />Lapp lactase deficiency or glucose and galactose malabsorption syndrome (rare hereditary diseases).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>interaction Antiarrhythmic drugs<br />Many antiarrythmics have depressant effects on cardiac automaticity, conduction and contractility.<br />Combined use of antiarrhythmics of different classes can have a beneficial therapeutic effect, but is most often problematic, and requires close clinical monitoring and ECG monitoring. Combined use of antiarrythmics that induce torsades de pointes (amiodarone, disopyramide, quinidines, sotalol, etc.) is contraindicated.<br />Combined use of antiarrhythmics of the same class is not recommended, except in exceptional cases, due to the higher risk of undesirable cardiac effects.<br />Combination with drugs that have negative inotropic properties, bradycardia-inducing effects and/or medicines that slow atrioventricular conduction can be problematic and requires clinical and ECG monitoring (amiodarone, bepridil, cibenzoline, diltiazem, disopyramide, dofetilide, flecainide, hydroquinidine, ibutilide, lidocaine, mexiletine, propafenone, quinidine, sotalol, verapamil).<br />Drugs with bradycardia-inducing effects<br />Many drugs can induce bradycardia, particularly class Ia antiarrythmics, beta-blockers, certain class</p><p>II antiarrhythmics, certain calcium channel blockers, digitalis glycosides, pilocarpine, anticholinesterase agents, etc.<br />Contraindicated combinations<br />+ Cisapride<br />Increased risk of ventricular arrhythmias, particularly torsades de pointes.<br />+ Dantrolene infusion<br />Cases of fatal ventricular fibrillation are regularly observed in animals following IV administration of verapamil and dantrolene. Therefore, combination of a calcium channel blocker with dantrolene is potentially dangerous. However, some patients have received concomitant treatment with nifedipine and dantrolene without any problems.<br />+ Dihydroergotamine<br />Ergotism with possible necrosis of the extremities (inhibited hepatic metabolism of rye ergot alkaloids).<br />+ Ergotamine<br />Ergotism with possible necrosis of the extremities (inhibited hepatic metabolism of rye ergot alkaloids).<br />+ Nifedipine<br />Significant increase in nifedipine concentrations due to reduction of its hepatic metabolism by diltiazem, with risk of severe hypotension.<br />+ Pimozide<br />Increased risk of ventricular arrhythmias, particularly torsades de pointes.<br />+ Sertindole<br />Increased risk of ventricular arrhythmias, particularly torsades de pointes.<br />Inadvisable combinations<br />+ Beta-blockers (excluding esmolol)<br />Automaticity disorders (excessive bradycardia, sinus arrest), sinoatrial and atrioventricular conduction disorders, and heart failure.<br />This combination requires close clinical and ECG monitoring, particularly in elderly subjects and at the start of treatment.<br />+ Beta-blockers used in the treatment of heart failure (bisoprolol, carvedilol, metoprolol,<br />nebivolol)<br />Negative inotropic effect with a risk of decompensation of heart failure, automaticity disorders<br />(bradycardia, sinus arrest) and sinoatrial and atrioventricular conduction disorders.<br />+ Esmolol, in patients with impaired left ventricular function</p><p>Automaticity disorders (excessive bradycardia, sinus arrest), sinoatrial and atrioventricular conduction disorders and heart failure.<br />+ Ivabradine<br />Increased ivabradine plasma concentrations and undesirable effects, particularly those affecting the heart (diltiazem inhibits the hepatic metabolism of ivabradine), adding to the bradycardia-inducing effects of these drugs.<br />+ Triazolam<br />Increased triazolam plasma concentrations due to reduced hepatic metabolism, with increased sedation.<br />Combinations requiring precautions for use<br />+ Alfentanil<br />Increased respiratory depressant effect of the opiate analgesic due to reduced hepatic metabolism. The dose of the analgesic should be adjusted if used with diltiazem.<br />+ Amiodarone<br />Risk of bradycardia and atrioventricular block, particularly in elderly subjects. Clinical and ECG monitoring.<br />+ Enzyme-inducing antiepileptic drugs<br />Reduced plasma concentrations of the calcium channel blocker due to increased hepatic metabolism by the inducer.<br />Clinical monitoring is required, and, if necessary, calcium channel blocker dose adjustment during and after treatment with the inducer.<br />+ Atorvastatin<br />Increased risk of undesirable effects (concentration-dependent) such as rhabdomyolysis due to reduced hepatic metabolism of the cholesterol-lowering drug. Lower doses of the cholesterol- lowering drug or another statin not affected by this type of interaction should be used.<br />+ Baclofen<br />Increased risk of hypotension, particularly postural hypotension.<br />Monitoring of blood pressure and antihypertensive dose adjustment if necessary.<br />+ Buspirone<br />Increased buspirone plasma concentrations due to reduction of its hepatic metabolism by diltiazem, with an increase in undesirable effects.<br />Clinical monitoring and buspirone dose adjustment if necessary.</p><p>+ Dronedarone<br />Risk of bradycardia and atrioventricular block, particularly in elderly subjects. Furthermore, a slight increase in dronedarone concentrations due to a reduction of its metabolism by the calcium channel blocker.<br />Calcium channel blocker treatment should be initiated at the minimum recommended dosage and the doses adjusted on the basis of the ECG.<br />+ Esmolol, in patients with normal left ventricular function<br />Automaticity disorders (excessive bradycardia, sinus arrest), sinoatrial and atrioventricular conduction disorders and heart failure.<br />Clinical and ECG monitoring.<br />+ Immunosuppressants (ciclosporin, everolimus, sirolimus, tacrolimus)<br />Increased blood concentrations of the immunosuppressant due to reduced metabolism.<br />Assay of the blood concentrations of the immunosuppressant, monitoring of kidney function and dose adjustment during and after treatment.<br />+ Midazolam<br />Increased plasma midazolam concentrations due to reduced hepatic metabolism, with increased sedation.<br />Clinical monitoring and reduction of dosage during treatment with diltiazem.<br />+ Medicinal products likely to induce torsades de pointes (excluding pimozide, cisapride): class Ia antiarrhythmics (quinidine, hydroquinidine, disopyramide); class III antiarrhythmics (amiodarone, dofetilide, ibutilide, sotalol); certain neuroleptics: phenothiazines (chlorpromazine, cyamemazine, fluphenazine, levomepromazine), benzamides (amisulpride, sulpiride, sultopride, tiapride), butyrophenones (droperidol, haloperidol), pimozide, pipamperone, pipotiazine, zuclopenthixol; other: bepridil, diphemanil, erythromycin IV, halofantrine, lumefantrine, methadone, mizolastine, moxifloxacin, pentamidine, spiramycin IV, vincamine IV<br />Increased risk of ventricular arrhythmias, particularly torsades de pointes.<br />Clinical and ECG monitoring.<br />+ Rifampicin<br />Reduced plasma concentrations of the calcium channel blocker due to increased hepatic metabolism.<br />Clinical monitoring and, if necessary, calcium channel blocker dose adjustment during and after treatment with rifampicin.</p><p>+ Simvastatin<br />Increased risk of undesirable effects (dose-dependent) such as rhabdomyolysis due to reduced hepatic<br />metabolism of the cholesterol-lowering drug. The dosage of 20 mg/day of simvastatin should not be exceeded, or another statin not affected by this type of interaction should be administered. Combinations to be taken into account<br />+ Alpha-blockers for urologic use (alfuzosin, doxazosin, prazosin, tamsulosin, terazosin)<br />Increased hypotensive effect. Increased risk of postural hypotension.<br />+ Amifostine<br />Increased risk of hypotension, particularly postural.<br />+ Imipramine antidepressants<br />Increased risk of hypotension, particularly postural.<br />+ Alpha-blocking antihypertensives<br />Increased hypotensive effect. Increased risk of postural hypotension.<br />+ Other bradycardia-inducing drugs<br />Risk of excessive bradycardia (additive effects).<br />+ Clonidine, guanfacine<br />Automaticity disorders (atrioventricular conduction disorders due to additive undesirable effects on conduction).<br />+ Glucocorticoids (excluding hydrocortisone used as replacement therapy) and mineralocorticoids<br />Reduced antihypertensive effect (corticosteroid water and sodium retention).<br />+ Neuroleptics<br />Increased risk of hypotension, particularly postural.<br />+ Pilocarpine<br />Risk of excessive bradycardia (additive bradycardic effects).<br />+ Nitrates, nitrites and related drugs<br />Increased risk of hypotension, particularly postural.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>lactation Pregnancy<br />Animal studies (rat, mouse, rabbit) have demonstrated teratogenic effects.<br />There are currently not enough data to evaluate the possible malformative and fetotoxic effect of diltiazem hydrochloride when administered during pregnancy. Therefore, use of diltiazem</p><p>hydrochloride is not recommended during pregnancy or in women of child-bearing potential not using contraceptives.<br />Lactation<br />Diltiazem is found at very low concentrations in breast milk.<br />However, breast-feeding should be avoided during treatment with diltiazem. If the use of diltiazem is necessary, the infant should be fed using an alternative method.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>On the basis of the adverse effects reported, such as dizziness (common), malaise (common), ability<br />to drive and use machines may be impaired. However, no studies have been performed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Classification of undesirable effects according to expected frequencies: very common (&ge; 1/10);<br />common (&ge; 1/100, &lt; 1/10); uncommon (&ge; 1/1,000, &lt; 1/100); rare (&ge; 1/10,000, &lt; 1/1,000); very rare (&lt; 1/10,000); not known (cannot be estimated from the available data).<br />Within each group frequency, undesirable effects are presented in order of decreasing seriousness.<br />Cardiac disorders<br />Common: atrioventricular block (which may be first, second or third degree; possible bundle-branch<br />block), palpitations. Uncommon: bradycardia.<br />Not known: sinoatrial block and congestive heart failure.<br />Vascular disorders<br />Effects caused by vasodilation (headache, flushing, and in particular, edema of the lower limbs) are<br />dose-dependent and are related to the pharmacological activity of the active substance. These occur more readily in elderly subjects.<br />Common: flushing.<br />Uncommon: postural hypotension.<br />Not known: vasculitis (including leukocytoclastic vasculitis).<br />Gastrointestinal disorders<br />Common: constipation, dyspepsia, epigastric pain, nausea.<br />Uncommon: vomiting, diarrhea. Rare: dry mouth.<br />Not known: gingival hyperplasia.</p><p>Skin and subcutaneous tissue disorders<br />Common: erythema.<br />Rare: urticaria.<br />Not known: angioedema, rash, erythema multiforme (particularly Stevens-Johnson syndrome and toxic epidermic necrolysis), exfoliative dermatitis, acute generalized exanthematous pustulosis, photosensitivity reaction (in particular lichenoid keratosis on areas of skin exposed to the sun), sweating, erythema, sometimes with fever and/or desquamation.<br />Hepatobiliary disorders<br />Uncommon: isolated, moderate, and generally transient increases in hepatic enzymes (AST, ALT,<br />LDH, alkaline phosphatase) have been observed during the initial treatment period. Not known: clinical hepatitis reversible on treatment discontinuation.<br />Nervous system disorders<br />Common: headache, dizziness.<br />Not known: extrapyramidal effects, generally reversible on treatment discontinuation.<br />Psychiatric disorders<br />Uncommon: nervousness, insomnia.<br />Not known: mood changes (especially depression).<br />Reproductive system disorders<br />Not known: gynecomastia generally reversible on treatment discontinuation.<br />General disorders and administration site conditions<br />Very common: swelling of the lower limbs. Common: malaise, asthenia.<br />Blood and lymphatic system disorders<br />Not known: thrombocytopenia.<br />To report any side effect(s):<br />Saudi Arabia<br />National Pharmacovigilance &amp; Drug Safety Centre (NPC):<br />Fax: +966-11-205-7662<br />Toll free phone: 8002490000<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npc<br />Sanofi - Pharmacovigilance: KSA_Pharmacovigilance@sanofi.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The clinical picture for massive acute poisoning can include marked hypotension that can progress to<br />collapse, sinus bradycardia with or without isorhythmic dissociation and atrioventricular conduction disorders.<br />The measures to be taken in a hospital environment include: gastric lavage, osmotic diuresis. Conduction disorders may benefit from temporary electrosystolic pacing.<br />The antidotes proposed are: atropine, adrenaline, vasopressor substances, positive inotropic and chronotropic agents, glucagon and calcium gluconate by infusion.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>SELECTIVE CALCIUM ANTAGONIST WITH DIRECT CARDIAC EFFECTS / BENZOTHIAZEPINE DERIVATIVES<br />(C08DB01: cardiovascular system)<br />Diltiazem slows calcium entry through membranes in vascular myocardial muscle fibre and smooth<br />muscle fibre and thus decreases the quantity of intracellular calcium reaching contractile proteins. In animals<br />Diltiazem increases coronary flow without causing the phenomenon of coronary steal. It acts on the small coronary arteries, on the large arterial trunks, on the collateral arteries. This vasodilator effect, which is exerted moderately on peripheral systemic arterial regions, is observed at doses which are not negatively inotropic.<br />In humans<br />Diltiazem increases coronary flow by reducing resistance.<br />Due to its moderate bradycardiac action and its moderate reduction in systemic arterial resistance, diltiazem reduces the cardiac workload.<br />No negative inotropic effect has been demonstrated on a healthy myocardium. Diltiazem induces a moderate slowing in heart rate and can have a depressant effect on a diseased sinus node. It slows down atrioventricular conduction, with a risk of atrioventricular block. Diltiazem has no effect on hisian and infra-hisian conduction.<br />The clinical efficacy of diltiazem has been demonstrated during controlled trials in all forms of angina.<br />On effort, the following have been observed: an improvement in performance,</p><p>a reduction in the amplitude of ST-segment depression (maximum at constant load, at constant HR and at constant double product).<br />Its remarkable activity in variant angina of Prinzmetal also demonstrates its marked protective effect against coronary spasm.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In humans, diltiazem demonstrates rapid intestinal absorption. It appears in the blood 30 minutes<br />after oral administration.<br />The peak plasma concentration is reached between the 3rd and the 4th hour. The apparent plasma half- life is 4 to 8 hours. Diltiazem is bound to plasma proteins in a proportion of 80-85%. Diltiazem is strongly metabolised by the liver; its main active metabolite is desacetyldiltiazem. Elimination is biliary (65%) and urinary (35%).<br />Only 0.2 to 0.4% unchanged diltiazem is found in the urine.<br />In general, there is a significant relationship between the dose absorbed and the plasma concentration. Any increase in this dose is followed by a proportional increase in the plasma level, suggesting the absence of any saturation phenomenon.<br />At constant dosage, the plasma levels are relatively constant.<br />There is a relationship between plasma concentration and efficacy. The plasma levels required to obtain satisfactory efficacy are, on average, between 70 and 200 ng/ml. It would appear the more severe the angina, the higher these plasma levels must be.<br />The pharmacokinetic profile is not modified in the event of impaired kidney function.<br />Plasma concentrations in the elderly and in subjects with impaired liver and kidney function are, on average, higher than in young subjects.<br />Diltiazem and its metabolites are barely dialysable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lactose, polyoxyethylene glycol 6000, hydrogenated castor oil, magn&eacute;sium stearate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 25&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>30, 50, 90 ou 100 tablets in heat-formed blister packs (PVC/Aluminium).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                sanofi-aventis France
1-13 boulevard Romain Rolland
75014 PARIS
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                18-10-2011
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>